Documente Academic
Documente Profesional
Documente Cultură
Detailing Guidelines:
Page 1
Doctor, presenting for the first time, study on Proanthocyanidin the major
active constituent of French Pine bark extract, the chief ingredient in
PYNOCARE, in the Treatment of Chloasma.
Page 3
Doctor, this was long term i.e. 1 year, open design clinical trial to investigate
the effect of orally administered Proanthocyanidin, on Chloasma.
The later intake of Proanthocyanidin rich extract for 5 months, may prevent
Chloasma from becoming worse, prior to the summer season.
D.Salina extract having the richest source of natural beta carotene and other
carotenoids provides systemic photoprotection and also prevents UV-induced
erythema formation.
Vitamin C & E derived from natural sources inhibit the acute UV-damages
such as erythema, sunburn and tanning as well as UV photoaging and skin
cancer.
Page 4:
Doctor, there are three more Clinical studies which were conducted on
Pynocare already shared with you. First, study done by Spin Control, France
on Thai patients, Second, a Published double blind study conducted by
HUKM, Malaysia on Malaysian patients and most recently another double
blind, placebo controlled study among Filipino women as published in the
International Journal of Dermatology, July 2009.
Recommended dose is 1-2 capsules twice daily after meals for minimum 12
weeks.